Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma

2018 ◽  
Vol 39 (9) ◽  
pp. 859-864 ◽  
Author(s):  
Abhishek Chatterjee ◽  
Tejpal Gupta ◽  
Venkatesh Rangarajan ◽  
Nilendu Purandare ◽  
Shreya Kunder ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Tumor Hypoxia ◽  
Emission Tomography ◽  
Optimal Timing ◽  
Positron Emission

scholarly journals 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in squamous cell carcinoma of the head and neck (literature review)

2019 ◽  
Vol 9 (3) ◽  
pp. 49-60
Author(s):  
О. D. Ryzhova ◽  
М. B. Dolgushin ◽  
A. I. Mikhaylov ◽  
Е. L. Dronova ◽  
D. I. Nevzorov ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Emission Tomography ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
Positron Emission ◽  
Fluorodeoxyglucose Positron Emission

Most of the malignant neoplasms of the head and neck are represented by squamous cell carcinoma. 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in squamous cell carcinoma of the head and neck is applied for primary staging, treatment planning, treatment response assessment evaluation and progression detection. The article presents a literature review on the use of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in head and neck squamous cell carcinoma patients, and major trends of other radiopharmaceuticals usage in this nosology.

Sign in / Sign up

Export Citation Format

Share Document